Host: Lee P. Shulman, MD, FACMG, FACOG

Guest: Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP

Guest: James A. Simon, MD, CCD, NCMP, IF, FACOG

While both medical therapy and surgery often play a role in a woman’s journey with endometriosis, it is less clear how to best sequence these approaches to optimize a patient’s outcomes. Under what circumstances should you consider using a GnRH antagonist either before or after conservative surgery? Join Drs. Lee Shulman, Ayman Al-Hendy, and James Simon as they provide their collective thoughts on how best to sequence a GnRH antagonist with conservative surgery when managing endometriosis.

Host: Lee P. Shulman, MD, FACMG, FACOG

Guest: Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP

Guest: Sawsan As-Sanie, MD

GnRH antagonists have emerged as a viable first-line (or subsequent-line) medical therapy for the management of endometriosis. They have proven to be effective and safe, and their use avoids the flare response observed with GnRH agonists. Join Drs. Lee Shulman, Ayman Al-Hendy, and Sawsan As-Sanie as they discuss the estrogen threshold hypothesis from the perspective of GnRH antagonists and delve into clinical data supporting the use of GnRH antagonists in the medical management of endometriosis.

Host: Lee P. Shulman, MD, FACMG, FACOG

Guest: Linda Bradley, MD

Guest: Melissa Simon, MD

The use of validated patient questionnaires, notably the SF-36 and EHP-30 scales, can greatly hasten the suspicion for an endometriosis diagnosis. Coupled with shared decision-making, or SDM, this patient-centered process can help ensure therapeutic adherence. Join Drs. Lee Shulman, Melissa Simon, and Linda Bradley as they discuss how to utilize the SF-36 and EHP-30 questionnaires in clinical practice and explore strategies to facilitate patient-healthcare provider discussions to improve overall short- and long-term patient outcomes.

Host: Lee P. Shulman, MD, FACMG, FACOG

Guest: Linda Bradley, MD

Guest: Melissa Simon, MD

Both provider- and patient-related healthcare disparities exist in the diagnosis and management of endometriosis. Many disparities derive from incorrect historical biases, while others are associated with social determinants of health, or SDOH. Join Drs. Lee Shulman, Linda Bradley, and Melissa Simon as they address these issues to help facilitate a patient-centered practice environment for all patients.

Host: Lee P. Shulman, MD, FACMG, FACOG

Guest: Sawsan As-Sanie, MD

Guest: Linda Bradley, MD

Endometriosis is often called a public health crisis for women. The delay in diagnosis can be greater than 10 years, during which time women suffer many physical and psychosocial issues that negatively impact their quality of life. Join Drs. Lee Shulman, Sawsan As-Sanie, and Linda Bradley as they identify strategies to overcome the diagnostic delay and its associated consequences.